Evidence map›Paper›PMID 33273713›Full record

ArticleNature biomedical engineering2020

Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device.

Jiyong Cheong, Hojeong Yu, Chang Yeol Lee, Jung-Uk Lee, Hyun-Jung Choi, Jae-Hyun Lee, Hakho Lee, Jinwoo Cheon

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jiyong Cheong *Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-6652-9394
Hojeong Yu *Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Chang Yeol LeeCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Jung-Uk LeeCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Hyun-Jung ChoiDepartment of Laboratory Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
Jae-Hyun LeeCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea. jhyun_lee@yonsei.ac.kr.ORCID http://orcid.org/0000-0002-9236-157X
Hakho LeeCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea. hlee@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-0087-0909
Jinwoo CheonCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea. jcheon@yonsei.ac.kr.ORCID http://orcid.org/0000-0001-8948-5929
Yonsei University · KRChonnam National University Hospital · KRHarvard University · US

Funding

Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with NanoplasmonicsU01CA233360 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CASTRO, CESAR M, DINULESCU, DANIELA M · 2018 to 2022
$3.5M
Clinical platform for high-throughput analyses of extracellular vesiclesR01CA229777 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, SKOG, JOHAN · 2018 to 2022
$3.2M
High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposureR21DA049577 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, PENDYALA, GURUDUTT · 2019 to 2020
$458k
Department of Defense DOD-W81XWH1910194Department of Defense DOD-W81XWH1910199Institute for Basic Science (IBS) IBS-R026-D1NCI NIH HHS R01 CA229777NCI NIH HHS U01 CA233360NIDA NIH HHS R21 DA049577
6 · The paper itself

Abstract

The diagnosis of severe acute respiratory syndrome 2 (SARS-CoV-2) infection by quantitative PCR with reverse transcription (RT-qPCR) typically involves bulky instrumentation in centralized laboratories and an assay time of 1-2 h. Here, we show that SARS-CoV-2 RNA can be detected in 17 min via a portable device integrating reverse transcription, fast thermocycling (via plasmonic heating through magneto-plasmonic nanoparticles) and in situ fluorescence detection following magnetic clearance of the nanoparticles. The device correctly classified all nasopharyngeal, oropharyngeal and sputum samples from 75 patients with COVID-19 and 75 healthy controls, with good concordance in fluorescence intensity with standard RT-qPCR (Pearson coefficients > 0.7 for the N1, N2 and RPP30 genes). Fast, portable and automated nucleic acid detection should facilitate testing at the point of care.

Identifiers

PMID33273713
PMCPMC8202505
OpenAlexW3110009900

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.